Lees J, Greening D, Rudd D, Cross J, Rosdah A, Lai X
J Mol Cell Cardiol Plus. 2025; 9():100085.
PMID: 39803589
PMC: 11708310.
DOI: 10.1016/j.jmccpl.2024.100085.
Yang T, Wu P, Jiang L, Chen R, Jin Q, Ye G
J Inflamm Res. 2024; 17:8861-8879.
PMID: 39569022
PMC: 11577436.
DOI: 10.2147/JIR.S486412.
Giuliani K, Adams B, Healy H, Kassianos A
Front Cell Dev Biol. 2024; 12:1497460.
PMID: 39544363
PMC: 11560912.
DOI: 10.3389/fcell.2024.1497460.
Nording H, Muller O
Mol Ther. 2024; 32(10):3217-3219.
PMID: 39317189
PMC: 11489530.
DOI: 10.1016/j.ymthe.2024.09.012.
Wang Y, Li F, Wei S, Li W, Wu J, Li S
Int J Nanomedicine. 2024; 19:7997-8014.
PMID: 39130683
PMC: 11317047.
DOI: 10.2147/IJN.S468394.
Adenosine 2A Receptor Agonism Improves Survival in Extracorporeal Cardiopulmonary Resuscitation.
Wisniewski A, Chancellor W, Young A, Money D, Beller J, Charlton J
J Surg Res. 2024; 301:404-412.
PMID: 39029264
PMC: 11758288.
DOI: 10.1016/j.jss.2024.06.033.
Reprogramming Exosomes to Escape from Immune Surveillance for Mitochondrial Protection in Hepatic Ischemia-Reperfusion Injury.
Liu S, Xiao X, Zhang L, Wang J, Zhao W, Liu H
Theranostics. 2024; 14(1):116-132.
PMID: 38164154
PMC: 10750206.
DOI: 10.7150/thno.88061.
Sodium Thiosulfate in Acute Myocardial Infarction: A Randomized Clinical Trial.
de Koning M, van Dorp P, Assa S, Pundziute-Do Prado G, Voskuil M, Anthonio R
JACC Basic Transl Sci. 2023; 8(10):1285-1294.
PMID: 38094689
PMC: 10714171.
DOI: 10.1016/j.jacbts.2023.06.001.
BAK contributes critically to necrosis and infarct generation during reperfused myocardial infarction.
Qin D, Jia X, Hanna A, Lee J, Pekson R, Elrod J
J Mol Cell Cardiol. 2023; 184:1-12.
PMID: 37709008
PMC: 10841630.
DOI: 10.1016/j.yjmcc.2023.09.004.
Age-Dependent Effects of Remote Preconditioning in Hypertensive Rat Hearts are Associated With Activation of RISK Signaling.
Farkasova F, Kindernay L, Ferko M, Rajtik T, Szobi A, Ravingerova T
Physiol Res. 2023; 72(S1):S11-S22.
PMID: 37294114
PMC: 10292815.
DOI: 10.33549/physiolres.935019.
Simultaneous Inhibition of Thrombosis and Inflammation Is Beneficial in Treating Acute Myocardial Infarction.
Vargas I, Grabau R, Chen J, Weinheimer C, Kovacs A, Dominguez-Viqueira W
Int J Mol Sci. 2023; 24(8).
PMID: 37108494
PMC: 10138953.
DOI: 10.3390/ijms24087333.
Integrated whole-genome gene expression analysis reveals an atlas of dynamic immune landscapes after myocardial infarction.
Wang Y, Chen Y, Zhang T
Front Cardiovasc Med. 2023; 10:1087721.
PMID: 36937942
PMC: 10020602.
DOI: 10.3389/fcvm.2023.1087721.
Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis MAPK signaling inhibition.
Chen W, Zhang Y, Wang Z, Tan M, Lin J, Qian X
Front Pharmacol. 2023; 14:1078205.
PMID: 36891270
PMC: 9986553.
DOI: 10.3389/fphar.2023.1078205.
Crocetin protects cardiomyocytes against hypoxia/reoxygenation injury by attenuating Drp1-mediated mitochondrial fission via PGC-1α.
Mou Y, Zhao R, Lyu S, Zhang Z, Zhu M, Liu Q
J Geriatr Cardiol. 2023; 20(1):68-82.
PMID: 36875162
PMC: 9975486.
DOI: 10.26599/1671-5411.2023.01.001.
Notoginsenoside R1 protects against myocardial ischemia/reperfusion injury in mice via suppressing TAK1-JNK/p38 signaling.
Zeng J, Shi H, Ren F, Zhao X, Chen Q, Wang D
Acta Pharmacol Sin. 2023; 44(7):1366-1379.
PMID: 36721009
PMC: 10310839.
DOI: 10.1038/s41401-023-01057-y.
Targeted delivery and ROS-responsive release of Resolvin D1 by platelet chimeric liposome ameliorates myocardial ischemia-reperfusion injury.
Weng X, Tan H, Huang Z, Chen J, Zhang N, Wang Q
J Nanobiotechnology. 2022; 20(1):454.
PMID: 36266658
PMC: 9585729.
DOI: 10.1186/s12951-022-01652-x.
Recombinant Klotho Protein Ameliorates Myocardial Ischemia/Reperfusion Injury by Attenuating Sterile Inflammation.
Myung J, Beom J, Kim J, Woo J, Park I, Chung S
Biomedicines. 2022; 10(4).
PMID: 35453645
PMC: 9032004.
DOI: 10.3390/biomedicines10040894.
Tropisetron Preconditioning Decreases Myocardial Biomarkers in Patients Undergoing Heart Valve Replacement Surgery.
Yu D, Gong X, Zhang Y, Li Q, Zhang M
Front Med (Lausanne). 2022; 9:690272.
PMID: 35425785
PMC: 9002259.
DOI: 10.3389/fmed.2022.690272.
Risk Factors for No-Reflow in Patients with ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Case-Control Study.
Yu Y, Wu Y, Wu X, Wang J, Wang C
Cardiol Res Pract. 2022; 2022:3482518.
PMID: 35308062
PMC: 8930256.
DOI: 10.1155/2022/3482518.
Purinergic signaling in myocardial ischemia-reperfusion injury.
Zhuang Y, Yu M, Lu S
Purinergic Signal. 2022; 19(1):229-243.
PMID: 35254594
PMC: 9984618.
DOI: 10.1007/s11302-022-09856-4.
